Nerve growth factor (NGF) potentiates the changes in striatal proenkephalin mrnas subsequent to 6-hydroxydopamine-induced lesions of the substantia nigra
Open Access
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 25 (3) , 401-405
- https://doi.org/10.1016/0361-9230(90)90227-q
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effect of Chronic Typical and Atypical Neuroleptic Treatment on Proenkephalin mRNA Levels in the Striatum and Nucleus Accumbens of the RatJournal of Neurochemistry, 1990
- NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult ratNeuron, 1989
- NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatumNeuron, 1989
- Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factorNature, 1987
- Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNAEuropean Journal of Pharmacology, 1986
- The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systemsNature, 1984
- Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the ratBrain Research, 1984
- Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesionsBrain Research, 1984
- DOPAMINE IN THE BASAL GANGLIA: Its Role and Therapeutic Implications (Including the Clinical Use of L-DOPA)British Medical Bulletin, 1973
- Demonstration and mapping out of nigro-neostriatal dopamine neuronsLife Sciences, 1964